Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VLM oncology
- Development stage
- Preclinical
- Lead developer
- Virothera Pharmaceuticals
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Gene Therapies, Nanoparticles → Drug Delivery Systems, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intravenous
01
Overview
Virothera Pharmaceuticals is developing a nucleic acid-based immunotherapy using its proprietary Virus Like Membranes (VLM) platform. This specific program targets the C-C chemokine receptor type 5 (CCR5) for the treatment of breast cancer. The VLM technology utilizes non-replicating, non-integrating viral-like particles to deliver DNA or RNA intended to modulate the immune system or directly target oncogenic pathways. In breast cancer, CCR5 signaling is associated with tumor progression, metastasis, and the recruitment of immunosuppressive cells to the tumor microenvironment; therefore, targeting this receptor aims to inhibit these processes. The program is currently in the preclinical stage of development.
- Other names
- Virus Like MembranesVLM-CCR5VLM-CCR-5VLM-CCR 5
02
Targets
CCR5 (C-C chemokine receptor type 5)
Beyond the preview
Go deeper on VLM oncology.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VLM oncology.